Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a pineal gland extract. It is studied primarily for telomerase activation and longevity effects.
Epithalon has been reported to stimulate telomerase activity and extend telomere length in cell studies, and to normalize melatonin secretion in aged subjects.
Commonly reported research ranges: 5–10 mg daily for short cycles (10–20 days), typically 2x yearly.
Dose should always be individualized. Factors that influence it include bodyweight, research goal, tolerance, and specific compound batch. The information below is educational, not a prescription.
A widely used reconstitution for a 10 mg vial is 2 ml of bacteriostatic water. With a typical 5000 mcg dose this works out to the unit count shown in the calculator below.
Short systemic half-life; biological effects reportedly longer.
This half-life informs how often Epithalon is typically dosed. Shorter half-lives usually mean more frequent dosing to maintain plasma levels; longer half-lives allow daily, weekly, or less-frequent administration depending on the compound.
This list reflects effects reported in available literature or user logs. It is not exhaustive. Adverse reactions should be discussed with a qualified clinician.
Lyophilized refrigerated. Reconstituted: refrigerated, use within 28 days.
Not FDA approved. Research use only.
For clinical-trial and primary-literature context, start with the sources below. We prioritize official drug labels, ClinicalTrials.gov records, and PubMed-indexed literature when available.
Peptide Protocol logs every dose, calculates reconstitution for you, and keeps your full protocol on one calm screen.
See the app →Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a pineal gland extract. It is studied primarily for telomerase activation and longevity effects.
Epithalon has been reported to stimulate telomerase activity and extend telomere length in cell studies, and to normalize melatonin secretion in aged subjects.
Commonly reported ranges are 5–10 mg daily for short cycles (10–20 days), typically 2x yearly. This is research information, not a recommendation — dosing should be individualized under clinical guidance.
Short systemic half-life; biological effects reportedly longer. This influences how often it is administered.
A common approach is to add 2 ml of bacteriostatic water to a 10 mg vial. Use the reconstitution calculator for exact unit counts.
Limited human safety data; Generally well tolerated in short cycles; Injection-site reactions.
Not FDA approved. Research use only.
Registered or published clinical-trial sources for Epithalon are listed in the references section below. Evidence depth varies widely by compound, so check the cited trial registries and primary literature before relying on any claim.
Sources listed above were used to verify the claims on this page. See our editorial policy for how we source information.
Educational use only. Peptide Protocol is an informational tool. Nothing on this page constitutes medical advice. Many peptides are prescription-only or restricted in your jurisdiction. Always consult a licensed healthcare professional before injecting any compound.